Timothy P Coughlin - Net Worth and Insider Trading

Timothy P Coughlin Net Worth

The estimated net worth of Timothy P Coughlin is at least $19 Million dollars as of 2024-12-27. Timothy P Coughlin is the CFO of Neurocrine Biosciences Inc and owns about 137,961 shares of Neurocrine Biosciences Inc (NBIX) stock worth over $19 Million. Timothy P Coughlin is the Director of aTyr Pharma Inc and owns about 56,000 shares of aTyr Pharma Inc (ATYR) stock worth over $211,120. Timothy P Coughlin is also the Director of Fate Therapeutics Inc and owns about 57,632 shares of Fate Therapeutics Inc (FATE) stock worth over $93,364. Details can be seen in Timothy P Coughlin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy P Coughlin has not made any transactions after 2024-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Timothy P Coughlin

To

Timothy P Coughlin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Timothy P Coughlin owns 4 companies in total, including Travere Therapeutics Inc (TVTX) , aTyr Pharma Inc (ATYR) , and Fate Therapeutics Inc (FATE) among others .

Click here to see the complete history of Timothy P Coughlin’s form 4 insider trades.

Insider Ownership Summary of Timothy P Coughlin

Ticker Comapny Transaction Date Type of Owner
TVTX Travere Therapeutics Inc 2015-03-31 director
ATYR aTyr Pharma Inc 2024-05-30 director
FATE Fate Therapeutics Inc 2022-06-03 director
LIMIT LIMIT 2017-02-06 VP and Chief Financial Officer

Timothy P Coughlin Latest Holdings Summary

Timothy P Coughlin currently owns a total of 3 stocks. Among these stocks, Timothy P Coughlin owns 137,961 shares of Neurocrine Biosciences Inc (NBIX) as of February 6, 2017, with a value of $19 Million and a weighting of 98.44%. Timothy P Coughlin owns 56,000 shares of aTyr Pharma Inc (ATYR) as of May 30, 2024, with a value of $211,120 and a weighting of 1.08%. Timothy P Coughlin also owns 57,632 shares of Fate Therapeutics Inc (FATE) as of June 3, 2022, with a value of $93,364 and a weighting of 0.48%.

Latest Holdings of Timothy P Coughlin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NBIX Neurocrine Biosciences Inc 2017-02-06 137,961 139.03 19,180,718
ATYR aTyr Pharma Inc 2024-05-30 56,000 3.77 211,120
FATE Fate Therapeutics Inc 2022-06-03 57,632 1.62 93,364

Holding Weightings of Timothy P Coughlin


Timothy P Coughlin Form 4 Trading Tracker

According to the SEC Form 4 filings, Timothy P Coughlin has made a total of 0 transactions in Neurocrine Biosciences Inc (NBIX) over the past 5 years. The most-recent trade in Neurocrine Biosciences Inc is the sale of 963 shares on February 6, 2017, which brought Timothy P Coughlin around $41,544.

According to the SEC Form 4 filings, Timothy P Coughlin has made a total of 1 transactions in aTyr Pharma Inc (ATYR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in aTyr Pharma Inc is the acquisition of 50,000 shares on May 30, 2024, which cost Timothy P Coughlin around $87,500.

According to the SEC Form 4 filings, Timothy P Coughlin has made a total of 1 transactions in Fate Therapeutics Inc (FATE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Fate Therapeutics Inc is the sale of 1,439 shares on June 3, 2022, which brought Timothy P Coughlin around $32,824.

Insider Trading History of Timothy P Coughlin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Timothy P Coughlin Trading Performance

GuruFocus tracks the stock performance after each of Timothy P Coughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy P Coughlin is 14.22%. GuruFocus also compares Timothy P Coughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy P Coughlin within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Timothy P Coughlin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Timothy P Coughlin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -12.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -16.16 LIMIT LIMIT LIMIT LIMIT LIMIT

Timothy P Coughlin Ownership Network

Ownership Network List of Timothy P Coughlin

No Data

Ownership Network Relation of Timothy P Coughlin

Insider Network Chart

Timothy P Coughlin Owned Company Details

What does Travere Therapeutics Inc do?

Who are the key executives at Travere Therapeutics Inc?

Timothy P Coughlin is the director of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include VP & Corp Controller and CAO Sandra Calvin , Chief Medical Officer Jula Inrig , and director & Chief Executive Officer Eric M Dube .

Travere Therapeutics Inc (TVTX) Insider Trades Summary

Over the past 18 months, Timothy P Coughlin made no insider transaction in Travere Therapeutics Inc (TVTX). Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 4,368 shares made by Christopher R. Cline , a net sale of 33,453 shares made by Eric M Dube , and a net sale of 8,264 shares made by Elizabeth E Reed .

In summary, during the past 3 months, insiders sold 92,090 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 92,090 shares. During the past 18 months, 159,574 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,574 shares.

Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Travere Therapeutics Inc Insider Transactions

No Available Data

Timothy P Coughlin Mailing Address

Above is the net worth, insider trading, and ownership report for Timothy P Coughlin. You might contact Timothy P Coughlin via mailing address: 339 North Granados Ave, Solana Beach Ca 92075.

Discussions on Timothy P Coughlin

No discussions yet.